HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC order

This article was originally published in The Tan Sheet

Executive Summary

The Federal Trade Commission files a stipulated final order against Stephen Karian and supplement marketers Great American Products and Physician's Choice for violating a court order in advertising for products. The original court order filed in 2005 specifically required the defendants clearly, prominently and frequently place paid advertising disclosures before product-ordering instructions during their infomercials for supplement products. The latest court order, filed Jan. 29, states the defendants must display a visual disclosure of paid advertising continuously throughout ordering instructions during TV ads and also requires audio paid advertising disclosures during radio and TV ads. The firms were ordered to pay the largest-ever FTC health fraud settlement in 2005 for deceptively claiming products increased human growth hormone levels (1"The Tan Sheet" June. 13, 2005, p. 18)...

You may also be interested in...



“Hormone Booster” Firms To Pay Largest Ever FTC Health Fraud Settlement

Marketers of products deceptively claiming to increase human growth hormone (HGH) levels are required to pay up to $20 mil. in consumer redress under a settlement, the Federal Trade Commission announced June 9

Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups

Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.

Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development

Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS137220

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel